A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on Telegram, where groups with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Content Removal
According to TikTok, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service safe and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of weight loss, glowing testimonials and detailed guides for preparing or administering at home.
After minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.
Product Information and Pricing
Inside these communities, messages show black plastic packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has already encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious health risks”.
